2025年5月29日 周四
Home > Archive>Volume 26, Issue 4, 2018 >429-432
PDF HTML XML Export Cite reminder
The role of Endoglin in atherosclerosis
Author:
Affiliation:

1.The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian 350004, China;2.Department of Geriatric Medicine, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China)

Clc Number:

R543

  • Article
    • | |
  • Metrics
    • |
  • Reference [33]
    • | | | |
  • Comments
    Abstract:

    Atherosclerosis is the pathological basis of cardiovascular and cerebrovascular diseases. Chronic inflammatory reaction and endothelial dysfunction play an important role in the occurrence and development of atherosclerosis. In recent years, some new markers of endothelial injury and inflammation have been identified, including Endoglin (CD105), Endocan, Apelin, and chemokines. This article mainly introduces the role of Endoglin in atherosclerosis.

    Reference
    [1] Santibaez JF, Quintanilla M, Bernabeu C.TGF-β/TGF-β receptor system and its role in physiological and pathological conditions.Clin Sci (Lond), 1,1(6):233-251.
    [2] Gougos A, Letarte M.Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line.J Immunol, 8,1(6):1 934-940.
    [3] Fernández-Ruiz E, St-Jacques S, Bellón T, et al.Assignment of the human endoglin gene (END) to 9q34—>qter.Cytogenet Cell Genet, 3,4(3-4):204-207.
    [4] Gougos A, Letarte M.Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.J Biol Chem, 0,5(15):8 361-364.
    [5] Bellón T, Corbí A, Lastres P, et al.Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions.Eur J Immunol, 3,3(9):2 340-345.
    [6] Lastres P, Letamendía A, Zhang H, et al.Endoglin modulates cellular responses to TGF-beta 1.J Cell Biol, 6,3(5):1 109-121.
    [7] Blanco FJ, Grande MT, Langa C, et al.S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology.Circ Res, 8,3(12):1 383-92.
    [8] López-Novoa JM, Bernabeu C.The physiological role of endoglin in the cardiovascular system.Am J Physiol Heart Circ Physiol, 0,9(4):H959-974.
    [9] Tian F, Zhou AX, Smits AM, et al.Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro.Biochem Biophys Res Commun, 0,2(3):283-288.
    [10] Ten DP, Goumans MJ, Pardali E.Endoglin in angiogenesis and vascular diseases.Angiogenesis, 8,1(1):79-89.
    [11] 蔡荣耀, 吴黎明.冠心病患者CD105、TGF-β1和MMP9的相关性及临床意义.医学理论与实践, 6,9(8):983-985.
    [12] Pepper MS.Transforming growth factor-beta:vasculogenesis, angiogenesis, and vessel wall integrity.Cytokine Growth Factor Rev, 7,8(1):21-43.
    [13] Li C, Hampson IN, Hampson L, et al.CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells.FASEB J, 0,4(1):55-64.
    [14] Conley BA, Smith JD, Guerrero-Esteo M, et al.Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques.Atherosclerosis, 0,3(2):323-335.
    [15] 李靓, 谢巍, 姜志胜, 等.我国动脉粥样硬化基础研究近三年进展.中国动脉硬化杂志, 5,3(11):1 182-188.
    [16] Rathouska J, Jezkova K, Nemeckova I, et al.Soluble endoglin, hypercholesterolemia and endothelial dysfunction.Atherosclerosis, 5,3(2):383-388.
    [17] Nachtigal P, Zemankova VL, Rathouska J, et al.The role of endoglin in atherosclerosis.Atherosclerosis, 2,4(1):4-11.
    [18] Sánchez-Elsner T, Botella LM, Velasco B, et al.Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways.J Biol Chem, 2,7(46):43 799-808.
    [19] Yoo JK, Kim J, Choi SJ, et al.The hsa-miR-5739 modulates the endoglin network in endothelial cells derived from human embryonic stem cells.Biochem Biophys Res Commun, 1,5(2):258-262.
    [20] Trostdorf F, Buchkremer M, Harmjanz A, et al.Fibrous cap thickness and smooth muscle cell apoptosis in high-grade carotid artery stenosis.Eur J Vasc Endovasc Surg, 5,9(5):528-535.
    [21] Ma X, Labinaz M, Goldstein J, et al.Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.Arterioscler Thromb Vasc Biol, 0,0(12):2 546-552.
    [22] Rathouska J, Vecerova L, Strasky Z, et al.Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.Pharmacol Res, 1,4(1):53-59.
    [23] Vecerova L, Strasky Z, Rathouska J, et al.Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice.J Atheroscler Thromb, 2,9(2):115-126.
    [24] Li C, Mollahan P, Baguneid MS, et al.A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and TGF beta 1.Pathobiology, 6,3(4):192-197.
    [25] Luque A, Turu M, Juan-Babot O, et al.Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques.Front Biosci, 8,3:6 483-490.
    [26] Li X, van der Meer JJ, van der Loos CM, et al.Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease.Histopathology, 2,1(1):88-97.
    [27] Piao M, Tokunaga O.Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta:an immunohistological study.J Atheroscler Thromb, 6,3(2):82-89.
    [28] Li CG, Bethell H, Wilson PB, et al.The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease.Atherosclerosis, 0,2(1):249-256.
    [29] Bot PT, Hoefer IE, Sluijter JP, et al.Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.Stroke, 9,0(2):439-447.
    [30] Cui S, Lü SZ, Chen YD, et al.Relationship between intravascular ultrasound imaging features of coronary plaques and soluble CD105 level in patients with coronary heart disease.Chin Med J (Engl), 7,0(7):595-597.
    [31] 曹秋玫, 宫海滨, 吕茜, 等.新生血管内皮细胞标志物可溶性CD105与冠心病危险程度的相关性研究.中国循环杂志, 2,7(1):33-36.
    [32] Ikemoto T, Hojo Y, Kondo H, et al.Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases.Heart Vessels, 2,7(4):344-351.
    [33] Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, et al.Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients.BMC Med, 0,8:86.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

KE Dou-Li, LIN Fan, ZHU Peng-Li. The role of Endoglin in atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(4):429-432.

Copy
Share
Article Metrics
  • Abstract:982
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:September 15,2017
  • Revised:December 14,2017
  • Online: May 04,2018
Article QR Code

You are the 50469 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025